QA: Rein Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001420565_2020_Rein_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001420565, Rein Therapeutics Inc

  xvar xval
0 AssetsCurrent 19,550,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 295,000
3 remainder_Assets 6,628,000
4 LiabilitiesCurrent 5,839,000
5 LiabilitiesNoncurrent 4,586,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,293,000
9 ResearchAndDevelopmentExpense 17,663,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 587,000
13 remainder_ComprehensiveNetIncome 12,000
  yvar yval
0 Assets 26,473,000
1 Liabilities 10,425,000
2 Expenses 29,956,000
3 Revenues 0
4 StockholdersEquity 16,048,000
5 NetIncome -29,369,000
6 ComprehensiveNetIncome -29,363,000
7 BaseVar 33,726,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.305
9 EconomicCapitalRatio 1.70

Edgar->Model Mapping

Feature Distribution

Change over Time